The dermatology devices market is expected to reach USD 14.17 billion by 2021 from USD 8.22 billion in 2016, at a CAGR of 11.50%. The global dermatology devices market is segmented based on diagnostic devices (by type and application) and treatment devices (by type and application).
On the basis of the type of diagnostic devices, the dermatology devices market is segmented into dermatoscopes, microscopes, and imaging devices. In 2016, the imaging devices segment is expected to account for the largest share of the dermatology diagnostic devices market. Growth in this segment can primarily be attributed to technological advancements and increasing awareness about aesthetic procedures.
On the basis of the application of treatment devices, the dermatology devices market is segmented into light therapy devices, lasers, electrosurgical equipment, liposuction devices, microdermabrasion devices, and cryotherapy devices. In 2016, the light therapy devices segment is expected to account for the largest share of the dermatology treatment devices market. Technological advancements in treatments and increasing incidence of skin disorders are the key factors propelling the growth of this segment.
Geographically, the dermatology devices market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily attributed to the rising incidence of skin disorders, increasing healthcare expenditure, and increasing awareness regarding aesthetic procedures.
Alma Lasers, Ltd.
Genesis Biosystems, Inc.
Heine Optotechnik GmbH & Co. Kg
Michelson Diagnostics, Ltd.
Valeant Pharmaceuticals International, Inc.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Dermatology Diagnostic Devices Market, By Type
7 Dermatology Treatment Devices Market, By Type
8 Dermatology Diagnostic Devices Market, By Application
9 Dermatology Treatment Devices Market, By Application